Barnett R (2018) Type 1 diabetes. Lancet 391:195. https://doi.org/10.1016/S0140-6736(18)30024-2

Article  PubMed  Google Scholar 

Wei W, Ehlerding EB, Lan X et al (2019) Molecular imaging of β-cells: diabetes and beyond. Adv Drug Deliv Rev 139:16–31. https://doi.org/10.1016/j.addr.2018.06.022

Article  CAS  PubMed  Google Scholar 

DiMeglio LA, Evans-Molina C, Oram RA (2018) Type 1 diabetes. Lancet 391:2449–2462. https://doi.org/10.1016/S0140-6736(18)31320-5

Article  PubMed  PubMed Central  Google Scholar 

Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368. https://doi.org/10.1056/NEJM198605223142106

Article  CAS  PubMed  Google Scholar 

Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82. https://doi.org/10.1016/S0140-6736(13)60591-7

Article  PubMed  Google Scholar 

Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38:1964–1974. https://doi.org/10.2337/dc15-1419

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sims EK, Besser REJ, Dayan C et al (2022) Screening for type 1 diabetes in the general population: a status report and perspective. Diabetes 71:610–623. https://doi.org/10.2337/dbi20-0054

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986. https://doi.org/10.1056/NEJM199309303291401

Article  Google Scholar 

Nathan DM, DCCT/EDIC Research Group (2014) The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37:9–16. https://doi.org/10.2337/dc13-2112

Article  CAS  PubMed  Google Scholar 

Winkler C, Krumsiek J, Buettner F et al (2014) Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes. Diabetologia 57:2521–2529. https://doi.org/10.1007/s00125-014-3362-1

Article  CAS  PubMed  Google Scholar 

Bonifacio E, Beyerlein A, Hippich M et al (2018) Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children. PLoS Med 15:e1002548. https://doi.org/10.1371/journal.pmed.1002548

Article  PubMed  PubMed Central  Google Scholar 

Luckett AM, Weedon MN, Hawkes G et al (2023) Utility of genetic risk scores in type 1 diabetes. Diabetologia 66:1589–1600. https://doi.org/10.1007/s00125-023-05955-y

Article  PubMed  PubMed Central  Google Scholar 

Markmann JF, Rickels MR, Eggerman TL et al (2021) Phase 3 trial of human islet-after kidney transplantation in type 1 diabetes. Am J Transplant 4:1477–1492. https://doi.org/10.1111/ajt.16174

Article  CAS  Google Scholar 

Hering BJ, Clarke WR, Bridges ND et al (2016) Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 7:1230–1240. https://doi.org/10.2337/dc15-1988

Article  CAS  Google Scholar 

Rickels MR, Eggerman TL, Bayman L et al (2022) Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation Consortium: the CIT-08 study. Diabetes Car 12:2967–2975. https://doi.org/10.2337/dc21-2688

Article  Google Scholar 

Campbell JE, Newgard CB (2021) Mechanisms controlling pancreatic islet cell function in insulin secretion. Nat Rev Mol Cell Biol 22(2):142–158. https://doi.org/10.1038/s41580-020-00317-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merrins MJ, Corkey BE, Kibbey RG, Prentki M (2022) Metabolic cycles and signals for insulin secretion. Cell Metab 34(7):947–968. https://doi.org/10.1016/j.cmet.2022.06.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eriksson O, Selvaraju R, Eich T et al (2016) Positron emission tomography to assess the outcome of intraportal islet transplantation. Diabetes 65:2482–2489. https://doi.org/10.2337/db16-0222

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toso C, Zaidi H, Morel P et al (2005) Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. Transplantation 79:353–355. https://doi.org/10.1097/01.tp.0000149501.50870.9d

Article  PubMed  Google Scholar 

Arifin DR, Bulte JWM (2021) In vivo imaging of pancreatic islet grafts in diabetes treatment. Front Endocrinol (Lausanne) 12:640117. https://doi.org/10.3389/fendo.2021.640117

Article  PubMed  Google Scholar 

Cahill D, Zamboni F, Collins MN (2019) Radiological advances in pancreatic islet transplantation. Acad Radiol 26:1536–1543. https://doi.org/10.1016/j.acra.2019.01.006

Article  PubMed  Google Scholar 

Eriksson O, Eich T, Sundin A et al (2009) Positron emission tomography in clinical islet transplantation. Am J Transplant 9:2816–2824. https://doi.org/10.1111/j.1600-6143.2009.02844.x

Article  CAS  PubMed  Google Scholar 

Laffon E, Marthan R (2020) 11C-(+)-PHNO trapping reversibility for quantitative PET imaging of β-cell mass in patients with type 1 diabetes. J Nuclear Med 61:1692–1693. https://doi.org/10.2967/jnumed.119.241075

Article  Google Scholar 

Eter WA, Parween S, Joosten L et al (2016) SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments. Sci Rep 6:24576. https://doi.org/10.1038/srep24576

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eter WA, Van der Kroon I, Andralojc K et al (2017) Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3. Sci Rep 7:7232. https://doi.org/10.1038/s41598-017-07815-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gimi B, Leoni L, Oberholzer J et al (2006) Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant 15:195–203. https://doi.org/10.3727/000000006783982151

Article  PubMed  Google Scholar 

Antkowiak PF, Tersey SA, Carter JD et al (2009) Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab 296:E573–E578. https://doi.org/10.1152/ajpendo.90336.2008

Article  CAS  PubMed  Google Scholar 

Virostko J (2020) Quantitative magnetic resonance imaging of the pancreas of individuals with diabetes. Front Endocrinol (Lausanne) 11:592349. https://doi.org/10.3389/fendo.2020.592349

Article  PubMed  Google Scholar 

Lemaire K, Chimienti F, Schuit F (2012) Zinc transporters and their role in the pancreatic β-cell. J Diabetes Investig 3:202–211. https://doi.org/10.1111/j.2040-1124.2012.00199.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lubag AJM, De Leon-Rodriguez LM, Burgess SC, Sherry AD (2011) Noninvasive MRI of β-cell function using a Zn2+-responsive contrast agent. Proc Natl Acad Sci USA 108:18400–18405. https://doi.org/10.1073/pnas.1109649108

Article  PubMed  PubMed Central  Google Scholar 

Dang HD, Chen H, Dargaville TR et al (2022) Cell delivery systems: toward the next generation of cell therapies for type 1 diabetes. J Cell Mol Med 26(18):4756–4767. https://doi.org/10.1111/jcmm.17499

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walker S, Appari M, Forbes S (2022) Considerations and challenges of islet transplantation and future therapies on the horizon. Am J Physiol Endocrinol Metab 322(2):E109–E117. https://doi.org/10.1152/ajpendo.00310.2021

Article  CAS  PubMed  Google Scholar 

Wassmer C-H, Lebreton F, Bellofatto K et al (2022) Bioengineering of pre-vascularized islet organoids for the treatment of type 1 diabetes. Transpl Int 35:10214. https://doi.org/10.3389/ti.2021.10214

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palikuqi B, Nguyen DT, Li G et al (2020) Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis. Nature 585(7825):426–432. https://doi.org/10.1038/s41586-020-2712-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Najjar M, Manzoli V, Abreu M et al (2015) Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice. Biotechnol Bioeng 112(9):1916–1926. https://doi.org/10.1002/bit.25589